Skip to main content

Emerald Coast Infectious Disease Acquired by RCap Equity

Hyde Park Capital acted as the exclusive financial advisor to Emerald Coast Infectious Disease for this transaction.

Healthcare
Mergers & Acquisitions

Emerald Coast Infectious Disease

Emerald Coast Infectious Disease, founded 17 years ago by Dr. Patrick Anastasio, is the premier provider of infectious disease care in the Emerald Coast of Florida. ECID specializes in the treatment of diseases such as MRSA, Tuberculosis, HIV/AIDS, HepC, travel health, tropical diseases, and common infections of the skin, lungs, kidneys, bones, and blood.

View Press Release
Logo: Emerald Coast Infectious Disease.
has been acquired by
Redrow logo with text
The undersigned acted as the exclusive financial advisor to Emerald Coast Infectious Disease for this transaction.
Back to Transactions

Related Services

Hyde Park Capital provides trusted investment banking expertise to business owners, executives, private equity firms, and strategic partners navigating critical transactions. Our senior-level team delivers objective advice, tailored strategies, and proven results that help clients maximize value and achieve lasting success.

See Related Industry Reports

Stay informed with our latest insights.

Healthcare Staffing Market Insights - Q1 2026 March 2026 View Reports Healthcare Technology Market Insights - Q4 2025 March 2026 View Reports Musculoskeletal Services Market Insights - Q1 2026 February 2026 View Reports Digital Health Market Insights Fall 2025 View Reports

Offices

Tampa – HQ

701 N Franklin St.
Tampa, FL 33602

Get Directions
Nashville

4235 Hillsboro Pike
STE 300
Nashville, TN 37215

Get Directions
San Francisco

505 Montgomery St.
STE 1106
San Francisco, CA 94111

Get Directions

Hyde Park Capital Advisors, LLC, member of FINRA and SIPC is the broker‑dealer subsidiary of Hyde Park Capital Partners.

All investments involve market risks, including the loss of principal. Past performance does not guarantee future results. Information on this website is not intended to be a recommendation or specific investment advice. Securities or companies mentioned are for illustrative purposes only and are not a recommendation to buy or sell. Information on this website is intended for US residents only and does not constitute an offer to buy or sell securities in any jurisdiction to whom it is not lawful to make such an offer. The testimonials shown may not be representative of the experience of other clients and are not guarantees of future performance or success and are not paid testimonials. 

You can review the background of our firm and investment professionals on FINRA’s BrokerCheck.